Announcement: 01/19/2017
IIHTT Publications

The Journal of the American Medical Association

Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss, The Idiopathic Intracranial Hypertension Treatment Trial April 23/30, 2014 Volume 311, Number 16

Editorial: Acetazolamide for Pseudotumor Cerebri, Evidence From the NORDIC Trial April 23/30, 2014 Volume 311, Number 16

JAMA Neurology

The Idiopathic Intracranial Hypertension Treatment Trial, Clinical Profile at Baseline Published online April 21, 2014

Editorial: Idiopathic Intracranial Hypertension, Important Questions Answered With More to Come Published online April 21, 2014

IIHTT Letter and Reply Published October 2014, Volume 71, Number 10

The Journal of Neuro-Ophthalmology

The Idiopathic Intracranial Hypertension Treatment Trial: Design Considerations and Methods Friedman et al: J Neuro-Ophthalmol 2014; 34: 107-117

Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial ten Hove et al: J Neuro-Ophthalmol 2015; 0:1-7

Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial Cello et al: J Neuro-Ophthalmol 2015; 0:1-7

The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait Beck: J Neuro-Ophthalmol 2016; 36: 1-3

Investigative Ophthalmology & Visual Science

Baseline Visual Field Findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) Invest. Ophthalmol. Vis. Sci. April 29, 2014 IOVS-14-14243

Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial, Part I: Quality Control, Comparisons, and Variability IOVS December 2014 Vol. 55 No. 12 8181

Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial, Part II: Correlations and Relationship to Clinical Features IOVS December 2014 Vol. 55 No. 12 8174

Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results IOVS May 2015 Vol. 56 No. 5 3298

Retinal and Choroidal Folds in Papilledema IOVS | September 2015 | Vol. 56 | No. 10 | 5671

SPIE Medical Imaging

Semi-Automated 2D Bruch's Membrane Shape Analysis in Papilledema Using Spectral-Domain Optical Coherence Tomography Medical Imaging 2015: Biomedical Applications in Molecular, Structural, and Functional Imaging, edited by Barjor Gimi, Robert C. Molthen, Proc. of SPIE Vol. 9417, 941721

American Academy of Ophthalmology

Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial Ophthalmology Volume 122, Number 9, September 2015

"Paton's folds" Revisited: Peripapillary Wrinkles, Folds and Creases in Papilledema Ophthalmology 2015

Papilledema Outcomes from the OCT Substudy of the Idiopathic Intracranial Hypertension Treatment Trial Ophthalmology. 2015 September ; 122(9): 1939–1945.e2. doi:10.1016/j.ophtha.2015.06.003.

American Academy of Neurology

Risk factors for poor visual outcome inpatients with idiopathic intracranialhypertension Neurology 85, September 1, 2015

Quality of life in idiopathic intracranial hypertension at diagnosis, IIH Treatment Trial results Neurology Neurology 84, June 16, 2015

Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial Neurology November 1, 2016 vol. 87 no. 18 1871-1877

Journal of Neurology

CSF pressure, papilledema grade, andresponse to acetazolamide in the IdiopathicIntracranial Hypertension Treatment Trial J Neurol, DOI 10.1007/s00415-015-7838-9

Journal of Neurological Sciences

Role of vitamin A metabolism in IIH: Results from the idiopathicintracranial hypertension treatment trial J. Libien et al. / Journal of the Neurological Sciences 372 (2017) 78–84

British Journal of Ophthalmology

Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial Michael Wall, Matthew J Thurtell, for the NORDIC IIHTT Study Group, BJO Online First, published on January 27, 2017 as 10.1136/bjophthalmol-2016-309852

American Journal of Ophthalmology

The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds Am J Ophthalmol 2017;176:77–86.  2016 Elsevier Inc.

The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6–12 Am J Ophthalmol 2017;176:102–107.  2017 Elsevier Inc.

Obesity Science & Practicd

A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension doi: 10.1002/osp4.34